Bacteriocin diversity: ecological and evolutionary perspectives
Introduction
Bacteriocins are loosely defined as biologically active protein moieties with a bacteriocidal mode of action 〚1〛, 〚2〛. The family includes a diversity of proteins in terms of size, microbial targets, modes of action and immunity mechanisms. They differ from traditional antibiotics in one critical way; they have a relatively narrow killing spectrum and are only toxic to bacteria closely related to the producing strain. These toxins have been found in all major lineages of Bacteria, and within a species tens or even hundreds of different kinds of bacteriocins are produced 〚2〛, 〚3〛. According to Klaenhammer, 99% of all bacteria may make at least one bacteriocin and the only reason more have not been isolated is that very few researchers have looked for them 〚4〛. It is clear that microbes invest considerable energy into the production and elaboration of these antimicrobial mechanisms. Less clear is how such diversity arose and what roles these biological weapons serve in microbial communities.
One family of bacteriocins, the colicins, has successfully served as a model for exploring such evolutionary and ecological questions. In this review, current knowledge of how the extraordinary range of colicin diversity arose and is maintained in microbial populations will be assessed and the role these toxins play in mediating microbial dynamics will be discussed.
The most extensively studied bacteriocins, the colicins produced by Escherichia coli, share certain key characteristics 〚5〛, 〚6〛, 〚7〛, 〚8〛, 〚9〛, 〚10〛, 〚11〛. Colicin gene clusters are encoded on plasmids and are comprised of a colicin gene, which encodes the toxin, an immunity gene, which encodes a protein conferring specific immunity to the producer cell, and a lysis gene, which encodes a protein involved in colicin release from the cell. Colicin production is mediated by the SOS regulon, and is therefore, principally produced under times of stress. Toxin production is lethal for the producing cell and any neighboring cells recognized by that colicin. A receptor domain in the colicin protein that binds a specific cell surface receptor determines target recognition. This mode of targeting results in the relatively narrow phylogenetic killing range often cited for bacteriocins. The killing functions range from pore formation in the cell membrane to nuclease activity against DNA, rRNA and tRNA targets. Colicins, indeed all bacteriocins produced by Gram-negative bacteria, are large proteins. Pore forming colicins range in size from 449 to 629 amino acids. Nuclease bacteriocins have an even broader size range, from 178 to 777 amino acids.
Although colicins are representatives of Gram-negative bacteriocins, there are intriguing differences found within this subgroup of the bacteriocin family. E. coli encodes its colicins exclusively on plasmid replicons 〚12〛. The nuclease pyocins of Pseudomonas aeruginosa, which share a recent ancestry with colicins, and other, as yet uncharacterized, bacteriocins are found exclusively on the chromosome 〚13〛. Another close relative to the colicin family, the bacteriocins of Serratia marcesens are found on both plasmids and chromosomes 〚14〛, 〚15〛, 〚16〛.
Many bacteriocins isolated from Gram-negative bacteria appear to have been created by recombination between existing bacteriocins 〚6〛, 〚17〛, 〚18〛, 〚19〛. Such frequent recombination is facilitated by the domain structure of bacteriocin proteins. In colicins, the central domain comprises about 50% of the protein and is involved in the recognition of specific cell surface receptors. The N-terminal domain (∼25% of the protein) is responsible for translocation of the protein into the target cell. The remainder of the protein houses the killing domain and the immunity region, which is a short sequence involved in immunity protein binding. Although the pyocins share a similar domain structure, the order of the translocation and receptor recognition domains are switched 〚20〛. As we shall explore further below, the conserved domain configuration of these toxins is responsible for much of the bacteriocin diversity we find in nature.
Section snippets
Colicins as a model for evolutionary studies
The colicins and other enteric bacteriocins, such as klebicins, remain the only bacteriocins for which detailed evolutionary investigations have been undertaken. Among the colicins there are two main evolutionary lineages, which also distinguish the two primary modes of killing: pore formation and nuclease activity 〚21〛. Studies that include DNA and protein sequence comparisons 〚6〛, 〚18〛, surveys of DNA sequence polymorphism in natural isolates 〚22〛, 〚23〛, 〚24〛, experimental evolution 〚25〛, 〚26〛
Ecological role of bacteriocins
Without question, bacteriocins serve some function in microbial communities. This statement follows from the detection of bacteriocin production in all surveyed lineages of prokaryotes. Equally compelling is the inference of strong positive selection acting on enteric bacteriocins. Such observations argue that these toxins play a critical role in mediating microbial population or community interactions. What remains in question is what, precisely, is that role?
Bacteriocins may serve as
Theoretical and experimental studies of bacteriocin ecology
Early experimental studies on the ecological role of bacteriocins were inconclusive and contradictory 〚42〛, 〚43〛, 〚44〛, 〚45〛, 〚46〛, 〚47〛, 〚48〛. More recently a theoretical and empirical base has been established that has defined the conditions that favor maintenance of toxin producing bacteria in both population and community settings. Almost exclusively, these studies have modeled the action of colicins. Chao and Levin showed that the conditions for invasion of a colicin producer strain were
Acknowledgments
We thank Carla Goldstone for her help in preparing this review and acknowledge financial support from the NIH GM 58433 and the Rockefeller Foundation.
References (59)
Bacteriocins of lactic acid bacteria
Biochimie
(1988)- et al.
Colicin Transport, Channel formation and inhibition
The long and short of colicin action: the molecular basis for the biological activity of channel-forming colicins
Structure
(1997)- et al.
Bacteriocin 28b, a chromosomally encoded bacteriocin produced by most Serratia marcesens biotypes
Res. Microbiol.
(1995) - et al.
Nucleotide polymorphism in microcin V Plasmids
Plasmid
(2001) - et al.
Positive selection and recombination: major molecular mechanisms in colicin diversification
Trends Ecol. Evol.
(1997) - et al.
Molecular characterization of the klebicin B plasmid of Klebsiella pneumoniae
Plasmid
(2001) - et al.
Complete nucleotide sequence of the structural gene for colicin A, a gene translated at a non-uniform rate
J. Mol. Biol.
(1983) - et al.
Characterization of the replication and mobilization regions of the multiresistance Klebsiella pneumoniae plasmid pJHCMW1
Plasmid
(1997) - et al.
Nucleotide sequence and gene organization of ColE1 DNA
J. Biol. Chem.
(1985)
Structure, expression and evolution of gene encoding the precursor of nisin, a small protein antibiotic
J. Biol. Chem.
Bacteriocins of Gram-positive bacteria
Bacteriol. Rev.
A survey of Col plasmids in natural isolates of Escherichia coli and an investigation into the stability of Col-plasmid lineages
J. Microbiol.
Colicins: structures, modes of actions, transfer through membranes, and evolution
Arch. Microbiol.
Structure–function of the channel-forming colicins
Annu. Rev. Biophys. Biomol. Struct.
The biology of E colicins: paradigms and paradoxes
Microbiology
Colicins and other bacteriocins with established modes of action
Annu. Rev. Microbiol.
Methods for studying colicins and their plasmids
Pyocins S1 and S2, Bacteriocins of Pseudomonas aeruginosa
Bacteriocin 28b from Serratia marcescens N28b: identification of Escherichia coli surface components involved in bacterocin binding and translocation
Can. J. Microbiol.
Genetic evidence for an activator required for induction of Colicin-like bacteriocin 28b production in Serratia marcescens by DNA-damaging agents
J. Bacteriol.
Assembly of colicin genes from a few DNA fragments. Nucleotide sequence of colicin D
Mol. Microbiol.
Positive selection for colicin diversity in bacteria
Mol. Biol. Evol.
Molecular evolution of E colicin plasmids with emphasis on the endonuclease types
Functional domains of S-type pyocins deduced from Chimeric molecules
J. Bacteriol.
Molecular mechanisms of bacteriocin evolution
Annu. Rev. Genet.
Nucleotide polymorphism in colicin E1 and Ia plasmids from natural isolates of Escherichia coli
Proc. Natl. Acad. Sci. USA
Cited by (237)
Efficacy of different treatments available against bacterial pathogens in fish
2022, Bacterial Fish DiseasesExpression of five class II bacteriocins with activity against Escherichia coli in Lacticaseibacillus paracasei CNCM I-5369, and in a heterologous host
2021, Biotechnology ReportsCitation Excerpt :Many AMPs have the particularity of being cationic and can bind and interact with the negatively charged bacterial cell membranes, causing leakage of intracellular constituents, ATP depletion and cell death [7]. Bacteriocins are a class of AMPs ribosomally synthesized by Gram-positive and Gram-negative bacteria [8,9], and are steadily reported for their positive clinical outcomes [10]. These safe molecules [11–13] can be of narrow or broad spectrum [14] which offers numerous advantages over clinical antibiotics.
Immunomodulatory and antiinflammatory mechanisms of probiotics
2021, Probiotics: Advanced Food and Health ApplicationsBeneficial microbes from human and animal intestines
2021, Probiotics: Advanced Food and Health ApplicationsConservation and similarity of bacterial and eukaryotic innate immunity
2024, Nature Reviews MicrobiologyImprovement of water quality with probiotics inclusion during simulated transport of Yellowfin Seabream Acanthopagrus latus larvae
2023, Journal of Aquatic Animal Health